The binding ability of ApDC was first studied, compared to KIT-d, the KIT-d-MMAE conjugate retained the same binding ability against GIST-T1 and GIST-430/654 cells (Figure 3B). This evidence concerns the gene KIT and gastrointestinal stromal tumor.